• MJHLS Brand Logo

© 2022 MJH Life Sciences™ , NeurologyLive – Clinical Neurology News and Neurology Expert Insights. All rights reserved.

European Committee for Treatment and Research in Multiple Sclerosis

Tackling Multiple Sclerosis With Combination Treatment Approaches, Biomarkers: Jeffrey Cohen, MD

November 29, 2021

The director of the Mellen Center for MS Treatment and Research at Cleveland Clinic discussed the possibility of using multiple DMTs to combat the effects of MS. [WATCH TIME: 3 minutes]

Greatest Recent Advancements in MS, Looking Toward the Future: Ilya Kister, MD

November 08, 2021

The professor of neurology at the NYU Grossman School of Medicine provided his thoughts on the most notable strides within the multiple sclerosis field in the past year. [WATCH TIME: 3 minutes]

Discontinuing Disease-Modifying Therapies in Multiple Sclerosis: Deborah Miller, PhD

November 04, 2021

The staff member at the Mellen Center for Multiple Sclerosis discussed reasons why patients may stop treatment, as well as strategies for maintaining communication with the healthcare team in the event of discontinuation. [WATCH TIME: 5 minutes]

ECTRIMS 2021: Key Takeaways, Data Highlights, and Ongoing Research

October 24, 2021

The NeurologyLive staff compiled highlights from our discussions with experts in one convenient location, following ECTRIMS 2021.

Telehealth and Integrative Medicine for Multiple Sclerosis: Megan Weigel, DNP, APRN-C, APHN-C, MSCN

October 22, 2021

Discussing a 6-week, virtual program conducted over Zoom, the founder of First Coast Integrative Medicine, spoke on the use of telehealth and future research efforts for integrative medicine in MS. [WATCH TIME: 3 minutes]

Episode 49: Altering the View of MS With a Topographical Model

October 22, 2021

"Mind Moments," a podcast from NeurologyLive, brings you an exclusive interview with Stephen Krieger, MD.

Discussing the Need for Patient Monitoring After Stopping Multiple Sclerosis Treatment

October 21, 2021

Deborah Miller, PhD, commented on strategies to maintain patient-provider communication following the discontinuation of disease-modifying therapies in MS.

‘Inspire MS’ and Integrative Medicine for Multiple Sclerosis: Megan Weigel, DNP, APRN-C, APHN-C, MSCN

October 21, 2021

The founder of First Coast Integrative Medicine spoke on a 6-week virtual program that introduced IM modalities, including guided journaling, nutrition, and yoga. [WATCH TIME: 3 minutes]

Long-Term Ocrelizumab, Satralizumab Data Offer Insights into MS and NMOSD Care

October 20, 2021

Ashish Pradhan, MD, the executive director and disease area lead for MS and NMOSD, Genentech, offered insight on a number of presentations at the 2021 ECTRIMS Congress.

Advances in MS Treatment, ECTRIMS 2021 Takeaways: Lawrence Steinman, MD

October 20, 2021

Discussing this year’s virtual ECTRIMS conference, the Zimmermann Professor of Neurology and Neurological Sciences, and Pediatrics at Stanford University provided his opinion on recent developments in the MS field. [WATCH TIME: 3 minutes]